Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$46.35 - $61.69 $315,180 - $419,492
-6,800 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$38.58 - $65.07 $262,344 - $442,475
6,800 New
6,800 $391,000
Q3 2019

Nov 14, 2019

SELL
$6.47 - $8.96 $115,237 - $159,586
-17,811 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$10.49 - $13.72 $186,837 - $244,366
17,811 New
17,811 $225,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.